Lupin incorporates wholly owned subsidiary for neuro-rehabilitation business
Mumbai: Lupin has informed in a BSE filing that the company has incorporated Lupin Atharv Ability Limited, wholly owned subsidiary, for neuro-rehabilitation business.
Medical Dialogues team had earlier reported that the company had announced the launch of its Satellite Laboratory in Vijayawada, Andhra Pradesh.
Read also: Lupin Diagnostics unveils Satellite Laboratory in Vijayawada
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
The Company specializes in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas. The company invested 7.9% of its revenue in research and development in FY23. Lupin has 15 manufacturing sites, 7 research centers, more than 20,000 professionals working globally, and has been consistently recognized as a ‘Great Place to Work’ in the Biotechnology & Pharmaceuticals sector.
Read also: Lupin bags USFDA nod for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
